Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Effect of tiered prescription copayments on the use of preferred brand medications.

Rector TS, Finch MD, Danzon PM, Pauly MV, Manda BS.

Med Care. 2003 Mar;41(3):398-406.

PMID:
12618643
2.

The effect of incentive-based formularies on prescription-drug utilization and spending.

Huskamp HA, Deverka PA, Epstein AM, Epstein RS, McGuigan KA, Frank RG.

N Engl J Med. 2003 Dec 4;349(23):2224-32.

3.

The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions.

Shrank WH, Hoang T, Ettner SL, Glassman PA, Nair K, DeLapp D, Dirstine J, Avorn J, Asch SM.

Arch Intern Med. 2006 Feb 13;166(3):332-7.

PMID:
16476874
4.

A bitter pill: formulary variability and the challenge to prescribing physicians.

Shrank WH, Ettner SL, Glassman P, Asch SM.

J Am Board Fam Pract. 2004 Nov-Dec;17(6):401-7.

5.

Impact of patient and plan design factors on switching to preferred statin therapy.

Cox ER, Kulkarni A, Henderson R.

Ann Pharmacother. 2007 Dec;41(12):1946-53. Epub 2007 Oct 30.

PMID:
17971409
6.

Effect of a three-tier prescription copay on pharmaceutical and other medical utilization.

Motheral B, Fairman KA.

Med Care. 2001 Dec;39(12):1293-304.

PMID:
11717571
7.
8.
9.

Incentive formularies and changes in prescription drug spending.

Landon BE, Rosenthal MB, Normand SL, Spettell C, Lessler A, Underwood HR, Newhouse JP.

Am J Manag Care. 2007 Jun;13(6 Pt 2):360-9.

10.
11.

Consumer response to dual incentives under multitiered prescription drug formularies.

Gilman BH, Kautter J.

Am J Manag Care. 2007 Jun;13(6 Pt 2):353-9.

12.

Impact of statin copayments on adherence and medical care utilization and expenditures.

Gibson TB, Mark TL, Axelsen K, Baser O, Rublee DA, McGuigan KA.

Am J Manag Care. 2006 Dec;12 Spec no.:SP11-9.

13.

Do consumers' attitudes predict prescription purchasing behavior?

Nair KV.

Manag Care Interface. 2003 Jun;16(6):22-7, 55.

PMID:
12841073
14.

Three-tiered-copayment drug coverage and use of nonsteroidal anti-inflammatory drugs.

Briesacher B, Kamal-Bahl S, Hochberg M, Orwig D, Kahler KH.

Arch Intern Med. 2004 Aug 9-23;164(15):1679-84.

PMID:
15302639
15.

Impact of 3-tier pharmacy benefit design and increased consumer cost-sharing on drug utilization.

Landsman PB, Yu W, Liu X, Teutsch SM, Berger ML.

Am J Manag Care. 2005 Oct;11(10):621-8.

16.
17.

Financial incentives and drug spending in managed care.

Hillman AL, Pauly MV, Escarce JJ, Ripley K, Gaynor M, Clouse J, Ross R.

Health Aff (Millwood). 1999 Mar-Apr;18(2):189-200.

PMID:
10091448
18.
19.
20.

Supplemental Content

Support Center